πŸ‡ΊπŸ‡Έ FDA
Patent

US 11572364

Pteridinone compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 11572364 (Pteridinone compounds and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61P, A61P35/00